Detection of SARS-CoV-2 within the healthcare environment: a multi-centre study conducted during the first wave of the COVID-19 outbreak in England.


Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
Feb 2021
Historique:
received: 01 10 2020
revised: 25 11 2020
accepted: 25 11 2020
pubmed: 2 12 2020
medline: 7 2 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

Understanding how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is spread within the hospital setting is essential in order to protect staff, implement effective infection control measures, and prevent nosocomial transmission. The presence of SARS-CoV-2 in the air and on environmental surfaces around hospitalized patients, with and without respiratory symptoms, was investigated. Environmental sampling was undertaken within eight hospitals in England during the first wave of the coronavirus disease 2019 outbreak. Samples were analysed using reverse transcription polymerase chain reaction (PCR) and virus isolation assays. SARS-CoV-2 RNA was detected on 30 (8.9%) of 336 environmental surfaces. Cycle threshold values ranged from 28.8 to 39.1, equating to 2.2 x 10 Effective cleaning can reduce the risk of fomite (contact) transmission, but some surface types may facilitate the survival, persistence and/or dispersal of SARS-CoV-2. The presence of low or undetectable concentrations of viral RNA in the air supports current guidance on the use of specific personal protective equipment for aerosol-generating and non-aerosol-generating procedures.

Sections du résumé

BACKGROUND BACKGROUND
Understanding how severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is spread within the hospital setting is essential in order to protect staff, implement effective infection control measures, and prevent nosocomial transmission.
METHODS METHODS
The presence of SARS-CoV-2 in the air and on environmental surfaces around hospitalized patients, with and without respiratory symptoms, was investigated. Environmental sampling was undertaken within eight hospitals in England during the first wave of the coronavirus disease 2019 outbreak. Samples were analysed using reverse transcription polymerase chain reaction (PCR) and virus isolation assays.
FINDINGS RESULTS
SARS-CoV-2 RNA was detected on 30 (8.9%) of 336 environmental surfaces. Cycle threshold values ranged from 28.8 to 39.1, equating to 2.2 x 10
CONCLUSIONS CONCLUSIONS
Effective cleaning can reduce the risk of fomite (contact) transmission, but some surface types may facilitate the survival, persistence and/or dispersal of SARS-CoV-2. The presence of low or undetectable concentrations of viral RNA in the air supports current guidance on the use of specific personal protective equipment for aerosol-generating and non-aerosol-generating procedures.

Identifiants

pubmed: 33259882
pii: S0195-6701(20)30548-X
doi: 10.1016/j.jhin.2020.11.024
pmc: PMC7831847
pii:
doi:

Substances chimiques

Aerosols 0
RNA, Viral 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-196

Subventions

Organisme : Medical Research Council
ID : MC_PC_19064
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Crown Copyright © 2020. Published by Elsevier Ltd. All rights reserved.

Auteurs

G Moore (G)

National Infection Service, Public Health England, Porton Down, Salisbury, UK. Electronic address: ginny.moore@phe.gov.uk.

H Rickard (H)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

D Stevenson (D)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

P Aranega-Bou (P)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

J Pitman (J)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

A Crook (A)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

K Davies (K)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

A Spencer (A)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

C Burton (C)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

L Easterbrook (L)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

H E Love (HE)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

S Summers (S)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

S R Welch (SR)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

N Wand (N)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

K-A Thompson (KA)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

T Pottage (T)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

K S Richards (KS)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

J Dunning (J)

Emerging Infections and Zoonoses Unit, National Infection Service, Public Health England, Colindale, London, UK; NIHR Health Protection Research Unit in Emerging Infections and Zoonoses, Liverpool, UK.

A Bennett (A)

National Infection Service, Public Health England, Porton Down, Salisbury, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH